A significant advance in cancer study is emerging with the use of mini-antibodies to re-engage damaged p53. This crucial tumor suppressor protein is frequently disabled in several types of malignancies, causing https://classifylist.com/story23959732/vhh-fragments-revive-tumor-suppressor-p53-a-promising-hope-for-cancer-therapy